Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Health care stocks are back in favor and these 3 names could lead the rally, according to the charts
12:24pm, Thursday, 11'th Jan 2024
Here are three stocks in the health care sector that could provide further upside potential based on their improving technical characteristics.
Dogs of the Dow: January's Top 3 Picks to Buy for Big Gains
04:53pm, Wednesday, 10'th Jan 2024
“The Dogs of the Dow” system involves purchasing the index's 10 stocks with the highest dividend yields at the end of each year. Using the technique has a few major advantages.
Xeris Biopharma inks exclusive worldwide license agreement with Amgen for XeriJect in thyroid eye disease
10:52am, Wednesday, 10'th Jan 2024
Xeris Biopharma Holdings (NASDAQ:XERS) announced an exclusive worldwide license agreement with Amgen for the development, manufacturing, and commercialization of a subcutaneous formulation of teprotum
3 health care stocks off to strong starts in 2024
07:01am, Wednesday, 10'th Jan 2024
Up 2% five trading days into the new year, global health care stocks have already matched their return for all of 2023. It's very early, but the sector has outpaced all other 10 economic groups since
How To Build A Dividend Growth Portfolio As A 'Young Investor' With $100,000
03:34pm, Monday, 08'th Jan 2024
How To Build A Dividend Growth Portfolio As A 'Young Investor' With $100,000
Amgen Inc. (AMGN) Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024 (Transcript)
03:32pm, Monday, 08'th Jan 2024
Amgen Inc. (AMGN) Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024 (Transcript)
Nvidia dives deeper into AI drug development with Amgen, Recursion partnerships
01:00pm, Monday, 08'th Jan 2024
Nvidia Corp. NVDA, +4.72% is doubling down on artificial-intelligence-powered drug discovery and development, announcing expanded partnerships Monday with Amgen Inc. AMGN, +1.26% and Recursion Pharmac
7 Rock-Solid Healthcare Dividend Stocks to Buy in January
09:10am, Saturday, 06'th Jan 2024
The Pharmaceutical segment offers human health pharmaceutical products in: Oncology, Hospital acute care Immunology Neuroscience Virology Cardiovascular and diabetes Vaccine products, such as preventi
How I Beat The Market Again In 2023
06:07pm, Friday, 05'th Jan 2024
I express frustration with the constant negativity surrounding the idea that beating the market is impossible for the average investor. I share my personal success in beating the market in 2023, with
Why the Market Dipped But Amgen (AMGN) Gained Today
07:34pm, Thursday, 04'th Jan 2024
Amgen (AMGN) reachead $303.17 at the closing of the latest trading day, reflecting a +0.82% change compared to its last close.
January Dogs Of The Dow: 2 Buyable, 6 Watchable
12:09pm, Thursday, 04'th Jan 2024
"The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation.is also a consideration.�
Revenge of the Boring Stocks! Dividends Are Sexy Again.
04:00pm, Wednesday, 03'rd Jan 2024
It's a new year and apparently there's a new theme on Wall Street for investors. Many of the Magnificent Seven stocks and their high-flying tech peers are off to a difficult start in 2024.
Amgen analysts boost target price on obesity drug data outlook
12:43pm, Wednesday, 03'rd Jan 2024
Amgen Inc (NASDAQ:AMGN, ETR:AMG) stock is poised to move higher in 2024 on a thesis its Phase II drug AMG133 for obesity will report positive data, according to Jefferies analysts. In an update to
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
10:31am, Wednesday, 03'rd Jan 2024
Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
There Are Only 5 Dow Stocks I Wouldn't Buy in 2024
10:00am, Friday, 29'th Dec 2023
The Dow is an excellent starting place if you are looking for foundational holdings. However, some Dow stocks would be best for investors to avoid right now.
